| Product NDC: | 33261-741 |
| Proprietary Name: | Alprazolam |
| Non Proprietary Name: | Alprazolam |
| Active Ingredient(s): | 1 mg/1 & nbsp; Alprazolam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 33261-741 |
| Labeler Name: | Aidarex Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078387 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091203 |
| Package NDC: | 33261-741-45 |
| Package Description: | 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (33261-741-45) |
| NDC Code | 33261-741-45 |
| Proprietary Name | Alprazolam |
| Package Description | 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (33261-741-45) |
| Product NDC | 33261-741 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Alprazolam |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20091203 |
| Marketing Category Name | ANDA |
| Labeler Name | Aidarex Pharmaceuticals LLC |
| Substance Name | ALPRAZOLAM |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |